BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 33164830)

  • 1. Non-coding RNAs: The key detectors and regulators in cardiovascular disease.
    Zhu L; Li N; Sun L; Zheng D; Shao G
    Genomics; 2021 Jan; 113(1 Pt 2):1233-1246. PubMed ID: 33164830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-coding RNAs regulating mitochondrial function in cardiovascular diseases.
    Ao X; Ding W; Li X; Xu Q; Chen X; Zhou X; Wang J; Liu Y
    J Mol Med (Berl); 2023 May; 101(5):501-526. PubMed ID: 37014377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases.
    Singh DD; Kim Y; Choi SA; Han I; Yadav DK
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA/circular noncoding RNA-miRNA-mRNA axes in cardiovascular diseases.
    Li M; Duan L; Li Y; Liu B
    Life Sci; 2019 Sep; 233():116440. PubMed ID: 31047893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Non-Coding RNA of Human Platelet in Cardiovascular Disease.
    Inzulza-Tapia A; Alarcón M
    Curr Med Chem; 2022; 29(19):3420-3444. PubMed ID: 34967288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotype-genotype network construction and characterization: a case study of cardiovascular diseases and associated non-coding RNAs.
    Wu R; Lin Y; Liu X; Zhan C; He H; Shi M; Jiang Z; Shen B
    Database (Oxford); 2020 Jan; 2020():. PubMed ID: 31942979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biological function and potential mechanism of long non-coding RNAs in cardiovascular disease.
    Zhang C; Han B; Xu T; Li D
    J Cell Mol Med; 2020 Nov; 24(22):12900-12909. PubMed ID: 33052009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between ubiquitin ligases and ncRNAs drives cardiovascular disease progression.
    You JR; Wen ZJ; Tian JW; Lv XB; Li R; Li SP; Xin H; Li PF; Zhang YF; Zhang R
    Front Immunol; 2024; 15():1335519. PubMed ID: 38515760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncoding RNAs in age-related cardiovascular diseases.
    Jusic A; Thomas PB; Wettinger SB; Dogan S; Farrugia R; Gaetano C; Tuna BG; Pinet F; Robinson EL; Tual-Chalot S; Stellos K; Devaux Y;
    Ageing Res Rev; 2022 May; 77():101610. PubMed ID: 35338919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaching Sex Differences in Cardiovascular Non-Coding RNA Research.
    Jusic A; Salgado-Somoza A; Paes AB; Stefanizzi FM; Martínez-Alarcón N; Pinet F; Martelli F; Devaux Y; Robinson EL; Novella S; On Behalf Of The Eu-CardioRNA Cost Action
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-coding RNA-mediated modulation of ferroptosis in cardiovascular diseases.
    Liu Y; Ding W; Wang J; Ao X; Xue J
    Biomed Pharmacother; 2023 Aug; 164():114993. PubMed ID: 37302320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive Oxygen Species Related Noncoding RNAs as Regulators of Cardiovascular Diseases.
    Dong Y; Xu W; Liu C; Liu P; Li P; Wang K
    Int J Biol Sci; 2019; 15(3):680-687. PubMed ID: 30745854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA: A new expectation for cardiovascular diseases.
    Xie Q; Ma Y; Ren Z; Gu T; Jiang Z
    J Cell Biochem; 2024 Feb; 125(2):e30512. PubMed ID: 38098251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review regulatory principles of non-coding RNAs in cardiovascular diseases.
    Li Y; Huo C; Pan T; Li L; Jin X; Lin X; Chen J; Zhang J; Guo Z; Xu J; Li X
    Brief Bioinform; 2019 Jan; 20(1):66-76. PubMed ID: 28968629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial noncoding RNA-regulatory network in cardiovascular disease.
    Jusic A; Devaux Y;
    Basic Res Cardiol; 2020 Mar; 115(3):23. PubMed ID: 32140778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapies Targeted at Non-Coding RNAs in Prevention and Limitation of Myocardial Infarction and Subsequent Cardiac Remodeling-Current Experience and Perspectives.
    Kowara M; Borodzicz-Jazdzyk S; Rybak K; Kubik M; Cudnoch-Jedrzejewska A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coding RNA in endothelial-to-mesenchymal transition.
    Hulshoff MS; Del Monte-Nieto G; Kovacic J; Krenning G
    Cardiovasc Res; 2019 Oct; 115(12):1716-1731. PubMed ID: 31504268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncoding RNAs in Cardiovascular Disease: Current Knowledge, Tools and Technologies for Investigation, and Future Directions: A Scientific Statement From the American Heart Association.
    Das S; Shah R; Dimmeler S; Freedman JE; Holley C; Lee JM; Moore K; Musunuru K; Wang DZ; Xiao J; Yin KJ;
    Circ Genom Precis Med; 2020 Aug; 13(4):e000062. PubMed ID: 32812806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-coding RNAs: key players in cardiac disease.
    Kreutzer FP; Fiedler J; Thum T
    J Physiol; 2020 Jul; 598(14):2995-3003. PubMed ID: 31291008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular Disease.
    Prestes PR; Maier MC; Woods BA; Charchar FJ
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.